Sperber K - Search Results

1

Localized Scleroderma: A Clinical Review.

Tratenberg M, Gutwein F, Rao V, Sperber K, Wasserrman A, Ash J. Tratenberg M, et al. Among authors: sperber k. Curr Rheumatol Rev. 2017;13(2):86-92. doi: 10.2174/1573397112666160907105434. Curr Rheumatol Rev. 2017. PMID: 27604889 Review.

2

Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases.

Sperber K, Hom C, Chao CP, Shapiro D, Ash J. Sperber K, et al. Pediatr Rheumatol Online J. 2009 May 13;7:9. doi: 10.1186/1546-0096-7-9. Pediatr Rheumatol Online J. 2009. PMID: 19439078 Free PMC article.

3

Cardiovascular Manifestations of Systemic Sclerosis: An Overview of Pathophysiology, Screening Modalities, and Treatment Options.

Lee KI, Manuntag LJ, Kifayat A, Manuntag SE, Sperber K, Ash JY, Frishman WH, Wasserman A. Lee KI, et al. Among authors: sperber k. Cardiol Rev. 2023 Jan-Feb 01;31(1):22-27. doi: 10.1097/CRD.0000000000000420. Epub 2021 Oct 6. Cardiol Rev. 2023. PMID: 34619709 Review.

4

Gout and hyperuricemia.

Chilappa CS, Aronow WS, Shapiro D, Sperber K, Patel U, Ash JY. Chilappa CS, et al. Among authors: sperber k. Compr Ther. 2010;36:3-13. Compr Ther. 2010. PMID: 21229813 Review.

5

Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy.

Abarientos C, Sperber K, Shapiro DL, Aronow WS, Chao CP, Ash JY. Abarientos C, et al. Among authors: sperber k. Expert Opin Drug Saf. 2011 Sep;10(5):705-14. doi: 10.1517/14740338.2011.566555. Epub 2011 Mar 22. Expert Opin Drug Saf. 2011. PMID: 21417950 Review.

6

Cardiac Manifestations of Systemic Lupus Erythematous: An Overview of the Incidence, Risk Factors, Diagnostic Criteria, Pathophysiology and Treatment Options.

Zagelbaum Ward NK, Linares-Koloffon C, Posligua A, Gandrabur L, Kim WY, Sperber K, Wasserman A, Ash J. Zagelbaum Ward NK, et al. Among authors: sperber k. Cardiol Rev. 2022 Jan-Feb 01;30(1):38-43. doi: 10.1097/CRD.0000000000000358. Cardiol Rev. 2022. PMID: 32991394 Review.

7

Selective regulation of cytokine secretion by hydroxychloroquine: inhibition of interleukin 1 alpha (IL-1-alpha) and IL-6 in human monocytes and T cells.

Sperber K, Quraishi H, Kalb TH, Panja A, Stecher V, Mayer L. Sperber K, et al. J Rheumatol. 1993 May;20(5):803-8. J Rheumatol. 1993. PMID: 8336306

8

Toll-like receptors: new therapeutic targets for the treatment of atherosclerosis, acute coronary syndromes, and myocardial failure.

Erickson B, Sperber K, Frishman WH. Erickson B, et al. Among authors: sperber k. Cardiol Rev. 2008 Nov-Dec;16(6):273-9. doi: 10.1097/CRD.0b013e3181709fd8. Cardiol Rev. 2008. PMID: 18923230 Review.

9

Vaccines in development to prevent and treat atherosclerotic disease.

Riley E, Dasari V, Frishman WH, Sperber K. Riley E, et al. Among authors: sperber k. Cardiol Rev. 2008 Nov-Dec;16(6):288-300. doi: 10.1097/CRD.0b013e3181885933. Cardiol Rev. 2008. PMID: 18923232 Review.

10

Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes.

Sperber K, Kalb TH, Stecher VJ, Banerjee R, Mayer L. Sperber K, et al. AIDS Res Hum Retroviruses. 1993 Jan;9(1):91-8. doi: 10.1089/aid.1993.9.91. AIDS Res Hum Retroviruses. 1993. PMID: 8427717

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters